New treatment option for Anesthesia
Official title Adverse Cardiovascular Events During Painless Gastroscopy Diagnosis and Treatment in Elderly Frail Patients
ClinicalTrials.gov ID: NCT06192082
What this study is testing
- What it's testing
- This study aims to compare the effects of conscious sedation and intravenous general anesthesia on cardiovascular events in frail patients undergoing digestive endoscopy diagnosis and treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 100
You may be able to join if
- Age greater than 65 years old, regardless of gender
- ASA is classified as Class II and III;
- BMI 18-28 kg/m2;
- Patients undergoing examination or treatment outside the operating room;
- FRAIL scale score ≥ 3 points 6 The patient voluntarily participated in this study and signed an informed consent form.
You likely can't join if
- 1 Those who are allergic or contraindicated to drugs such as benzodiazepines, opioids, propofol, and their drug components;
- 2\. Acute heart failure; Unstable angina pectoris; Myocardial infarction occurred within 6 months prior to screening; Resting electrocardiogram heart...
- 3\. Patients with severe respiratory diseases (acute respiratory infections, acute exacerbations of chronic obstructive pulmonary disease...
- 4\. Patients who have not received formal antihypertensive treatment or have poor blood pressure control;
- 5\. Patients with traumatic brain injury, possible presence of intracranial hypertension, cerebral aneurysms, history of cerebrovascular accidents...
- 6\. Individuals with mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder, etc.), long-term history of taking psychotropic...
See the full eligibility criteria
- Age greater than 65 years old, regardless of gender
- ASA is classified as Class II and III;
- BMI 18-28 kg/m2;
- Patients undergoing examination or treatment outside the operating room;
- FRAIL scale score ≥ 3 points 6 The patient voluntarily participated in this study and signed an informed consent form.
- 1 Those who are allergic or contraindicated to drugs such as benzodiazepines, opioids, propofol, and their drug components;
- 2\. Acute heart failure; Unstable angina pectoris; Myocardial infarction occurred within 6 months prior to screening; Resting electrocardiogram heart rate\<50 beats/minute; Third degree atrioventricular transmission...
- 3\. Patients with severe respiratory diseases (acute respiratory infections, acute exacerbations of chronic obstructive pulmonary disease, uncontrolled asthma, etc.);
- 4\. Patients who have not received formal antihypertensive treatment or have poor blood pressure control;
- 5\. Patients with traumatic brain injury, possible presence of intracranial hypertension, cerebral aneurysms, history of cerebrovascular accidents, and central nervous system diseases;
- 6\. Individuals with mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder, etc.), long-term history of taking psychotropic drugs, and cognitive impairment;
- 7\. Other situations that have been determined by the researcher to be unsuitable for inclusion.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.